Seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a London NHS Trust

Healthcare workers (HCWs) have a theoretically increased risk of contracting severe acute respiratory coronavirus virus 2 (SARS-CoV-2) given their occupational exposure. We tested 2,167 HCWs in a London Acute Integrated Care Organisation for antibodies to SARS-CoV-2 in May and June 2020 to evaluate...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Infection control and hospital epidemiology 2021-02, Vol.42 (2), p.212-214, Article 0899823
Hauptverfasser:	Grant, Joseph J., Wilmore, Stephanie M. S., McCann, Naina S., Donnelly, Owain, Lai, Rebecca W. L., Kinsella, Matthew J., Rochford, Helena L., Patel, Trupti, Kelsey, Michael C., Andrews, Julie A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Antibodies Antibodies, Viral - blood Asymptomatic Concise Communication Coronaviruses COVID-19 COVID-19 - diagnosis COVID-19 - epidemiology COVID-19 - immunology COVID-19 - virology COVID-19 Serological Testing - methods Disease control Disease transmission Ethnicity Health care Health Personnel - statistics & numerical data Humans Illnesses Infections Infectious Diseases Laboratories Life Sciences & Biomedicine London - epidemiology Masks Medical personnel Middle Aged Occupational exposure Occupational Exposure - statistics & numerical data Pandemics Patients Personal protective equipment Public, Environmental & Occupational Health Risk Factors SARS-CoV-2 - genetics SARS-CoV-2 - immunology Science & Technology Seroepidemiologic Studies Serology Severe acute respiratory syndrome coronavirus 2 Social distancing State Medicine Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Healthcare workers (HCWs) have a theoretically increased risk of contracting severe acute respiratory coronavirus virus 2 (SARS-CoV-2) given their occupational exposure. We tested 2,167 HCWs in a London Acute Integrated Care Organisation for antibodies to SARS-CoV-2 in May and June 2020 to evaluate seroprevalence. We found a seropositivity rate of 31.6% among HCWs.
ISSN:	0899-823X 1559-6834
DOI:	10.1017/ice.2020.402